comparemela.com

Latest Breaking News On - Pharmaceuticals trading down - Page 28 : comparemela.com

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) CFO Sells $234,640.00 in Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CFO Timothy Eugene Sullivan sold 4,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, April 1st. The stock was sold at an average price of $58.66, for a total transaction of $234,640.00. Following the sale, the chief financial officer now directly owns 93,338 shares of […]

Timothy-eugene-sullivan
Apellis-pharmaceuticals
Needham-company
First-horizon-advisors-inc
Citigroup
Apellis-pharmaceuticals-inc
Apellis-pharmaceuticals-trading-down
News-ratings-for-apellis-pharmaceuticals-daily
Advisor-group-holdings-inc
Quarter-for-apellis-pharmaceuticals
Cim-investment-management-inc
Nasdaq

Farmers & Merchants Trust Co of Chambersburg PA Buys New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Farmers & Merchants Trust Co of Chambersburg PA bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 313 shares of the pharmaceutical company’s stock, valued at approximately $127,000. Other large […]

Zurcher-kantonalbank-zurich-cantonalbank
Ourania-tatsis
Amit-sachdev
Sherbrooke-park-advisers
Canaccord-genuity-group
Quarter-for-vertex-pharmaceuticals
Maxim-group
Morgan-stanley
Farmers-merchants-trust-co
Exchange-commission
Vertex-pharmaceuticals-trading-down
Vertex-pharmaceuticals

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of "Buy" by Brokerages

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average rating of “Buy” from the seven research firms that are currently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have updated their coverage on the […]

United-states
America
Craig-hallum
Thomass-mchugh
Piper-sandler
Analyst-recommendations-for-avadel-pharmaceuticals
Institutional-investors-weigh-in-on-avadel-pharmaceuticals
Needham-company
Avadel-pharmaceuticals
News-ratings-for-avadel-pharmaceuticals-daily
Avadel-pharmaceuticals-trading-down
Samsara-biocapital

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Sees Large Increase in Short Interest

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Sees Large Increase in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Eugene-schneider
Pingora-partners
Ionis-pharmaceuticals-inc
Insider-activity-at-ionis-pharmaceuticals
Almanack-investment-partners
Jpmorgan-chase-co
Royal-bank
Nasdaq
Ionis-pharmaceuticals-trading-down
Peoples-bank

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $21,715.00 in Stock

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $21,715.00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

France
China
United-states
Floydf-petersen
Mcglone-suttner-wealth-management-inc
Jpmorgan-chase-co
Amphastar-pharmaceuticals-trading-down
News-ratings-for-amphastar-pharmaceuticals-daily
Principal-securities-inc
Amphastar-pharmaceuticals-inc
Quarter-for-amphastar-pharmaceuticals
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.